SCHEMBL16635971

SCHEMBL16635971

CCCCOC(=O)C1CCC(F)(F)CC1C(=O)Cl

nearest known ligand 0.38

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 7/20 0.34
ALDH1A1 P00352 1/20 0.34
CHRM2 P08172 1/20 0.33
CHRM4 P08173 1/20 0.33
CHRM5 P08912 1/20 0.33
CHRM1 P11229 1/20 0.33
CHRM3 P20309 1/20 0.33
ATM Q13315 1/20 0.33
RAB9A P51151 1/20 0.32
LMNA P02545 1/20 0.31
HTT P42858 1/20 0.31
HPGD P15428 1/20 0.31
TSHR P16473 1/20 0.31
PRKCA P17252 2/20 0.30
ESR1 P03372 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7669796 0.79 ALDH1A1 (0.52) EPHX2ALDH1A1CHRM2CHRM4CHRM5
SCHEMBL7669797 0.79 ALDH1A1 (0.52) EPHX2ALDH1A1CHRM2CHRM4CHRM5
SCHEMBL9450418 0.75 KCNQ3 (0.33)
SCHEMBL22872240 0.75 ALDH1A1 (0.44) EPHX2ALDH1A1CHRM2CHRM4CHRM5
SCHEMBL1298046 0.74 ALDH1A1 (0.54) ALDH1A1CHRM2CHRM4CHRM5CHRM1
SCHEMBL16433766 0.73 ALDH1A1 (0.45) ALDH1A1CHRM2CHRM4CHRM5CHRM1
SCHEMBL15127989 0.72 ALDH1A1 (0.48) ALDH1A1CHRM2CHRM4CHRM5CHRM1
SCHEMBL813586 0.72 ALDH1A1 (0.48) EPHX2ALDH1A1CHRM2CHRM4CHRM5
SCHEMBL2583177 0.72 ALDH1A1 (0.48) EPHX2ALDH1A1CHRM2CHRM4CHRM5
SCHEMBL2251674 0.72 ALDH1A1 (0.48) EPHX2ALDH1A1CHRM2CHRM4CHRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3054947-A1 CATHEPSIN CYSTEINE PROTEASE INHIBITORS Merck Sharp & Dohme Corp. (US) 2016-08-17 EP disclosed
WO-2015054038-A1 CATHEPSIN CYSTEINE PROTEASE INHIBITORS MERCK SHARP & DOHME CORP. (US) 2015-04-16 WO disclosed